Roble Belko & Company’s Solventum SOLV Stock Holding History

Roble Belko & Company’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Hold	150	–	–	﹤0.01%	300
2026 Q1	$10K	Hold	150	–	–	﹤0.01%	310
2025 Q4	$12K	Buy	+150	New	+$11.5K	﹤0.01%	296

Other funds holding SOLV

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TFM

Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Roble Belko & Company's SOLV Position: Q2 2026 in Review

Roble Belko & Company held its Solventum (SOLV) position steady in Q2 2026 at 150 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Roble Belko & Company first reported a position in SOLV in Q4 2025 and has held it in 3 quarters since. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

Roble Belko & Company held 150 shares of Solventum worth $12K as of Q2 2026.
Roble Belko & Company left its Solventum share count unchanged in Q2 2026.
Solventum made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #300 holding.
Roble Belko & Company first reported a position in Solventum in Q4 2025 and has held it in 3 quarters since.
875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.